Core Insights - Mobile-health Network Solutions (MNDR) has secured a strategic investment of US$900,000 from Indopacific Health Investment Corporation to enhance its growth strategy and market entry in Indonesia [1][3] - The investment follows an earlier subscription of US$150,000 in May 2025, bringing Indopacific's total investment in MNDR to US$1.05 million [3] - The funds will primarily be allocated for the acquisition of Lifepack, a digital pharmacy platform in Indonesia, and to support broader market initiatives across Southeast Asia [3][4] Investment Details - The share purchase was executed under a Securities Purchase Agreement dated September 10, 2025, with shares priced at US$1.80 each [2] - The transaction includes customary closing conditions and lock-up provisions in accordance with Nasdaq requirements [2] Company Overview - Mobile-health Network Solutions is an AI-powered digital health platform based in Singapore, with operations across Southeast Asia and plans to expand into the US [5] - The company focuses on providing telemedicine, AI-driven health tools, and virtual clinic infrastructure to enhance healthcare accessibility [5]

Company Overview - Mobile-health Network Solutions (MNDR) is a leading AI-powered digital healthcare platform provider headquartered in Singapore, with operations across Southeast Asia and expanding into the US [9] - Jospong Group of Companies is a diversified Ghanaian holding company with over 70 subsidiaries, operating in sectors such as waste management, banking, healthcare, insurance, logistics, and real estate [10][11] Partnership Details - MNDR and Jospong have signed a Memorandum of Understanding (MOU) to form a joint venture aimed at launching and operating MNDR's AI-powered digital health platform in Ghana [1][2] - The partnership combines MNDR's telehealth and AI-driven technology with Jospong's local market knowledge and capital resources, designed to accelerate the platform's market entry [2] Market Context - Ghana, with a population exceeding 33 million, is identified as a key market for healthcare innovation, benefiting from a similar institutional framework to other Commonwealth nations [3] - The joint venture aims to address the significant need for accessible healthcare solutions in Ghana, particularly in rural areas, by connecting patients with medical professionals through remote consultations [4] Strategic Goals - The collaboration is expected to enhance healthcare affordability, accessibility, and availability across Africa, serving as a blueprint for future regional expansion [6] - Both companies are committed to a swift and comprehensive due diligence process to finalize the joint venture agreement [6]

Core Viewpoint - Mobile-health Network Solutions has launched AI Checker, an AI-powered tool designed to enhance the quality of doctors' telehealth notes by providing immediate feedback on omissions or errors, marking a significant advancement towards developing a fully autonomous AI doctor [1][4][5]. Group 1: AI Checker Features - AI Checker is an automated, cloud-based system that evaluates doctors' notes against the QNOTE framework, which includes 12 critical areas of clinical documentation [2]. - The system is trained on over three million anonymized consults and is estimated to possess more medical knowledge than typical human doctors, providing immediate reminders for any deficiencies in documentation [3]. - The tool aims to improve patient care, reduce audit risks, and enhance documentation quality for healthcare providers [3][5]. Group 2: Future Developments - The co-founder and co-CEO of the company, Dr. Siaw Tung Yeng, stated that AI Checker is a foundational step towards creating a fully autonomous AI doctor that combines AI precision with human compassion [4][7]. - Future iterations of AI Checker are expected to include capabilities such as real-time health monitoring, preventive screening prompts, lifestyle coaching, and autonomous triage in underserved areas [7]. Group 3: Security and Compliance - AI Checker is built on a cloud infrastructure that is ISO 27001 and SOC 2 certified, ensuring data privacy, compliance, and global scalability [8]. Group 4: Industry Position - The company positions itself as a leader in the telehealth industry, aiming to usher in a new era of AI-powered healthcare solutions [9].

Core Insights - Mobile-health Network Solutions (MNDR) has been awarded the 2025 Brands For Good Distinction Award in the category of Technology For Good, recognizing its contributions to social and environmental challenges [1][2] - The award ceremony took place on July 23, 2025, in Singapore, celebrating 41 companies from 80 nominations, highlighting the significance of technology in addressing societal issues [2][3] - MNDR's co-CEO, Dr. Siaw Tung Yeng, emphasized the company's commitment to improving healthcare accessibility through AI technology, which has been integrated into three innovative products in 2025 [4][7] Product Innovations - The first product, AI Agent, launched in January 2025, aims to reduce administrative burdens on healthcare providers and enhance workflow efficiency [4] - The second product, AI Notes, introduced in March 2025, automates the documentation process by capturing doctor-patient conversations and generating structured clinical notes in real-time [5] - The third product, AI Checker, deployed earlier this month, provides immediate feedback on the quality of doctors' consultations by evaluating notes against the QNOTE framework, a recognized medical standard [6] Company Overview - Mobile-health Network Solutions is a leading AI-powered digital health platform based in Singapore, with operations across Southeast Asia and plans for expansion into the US [9] - The company's mission is to make healthcare accessible, intelligent, and human through technology, providing telemedicine and AI-driven health tools [10]

Core Insights - Mobile-health Network Solutions (MNDR) launched an at-the-market (ATM) equity offering to raise up to $300 million to accelerate the growth of its AI-powered digital health platform [1][3] - The company aims to use the proceeds to develop large language models for diagnostics, expand AI-driven teleconsultation services in Asia, and build a pharmacy delivery infrastructure [3][4] Financial Performance - MNDR reported revenue of $4.3 million for the six-month period ended December 31, 2024, down from $6.6 million in the same period a year earlier [4][5] - The decline in revenue was attributed to the closure of a clinic in Singapore, which reduced telemedicine service usage, although sales of medicine and medical devices increased [5] Strategic Initiatives - In the first half of 2025, MNDR secured $10 million in funding for its AI Agent, launched AI Notes for transcribing doctor-patient conversations, acquired Indonesian pharmacy and telehealth platform Lifepack, and announced plans for a tele-dentistry service [6] - The company is optimistic about recovering and surpassing previous revenue levels, aiming for breakeven by the second half of FY2025 and profitability before the first half of FY2027 [7] Market Trends - Telehealth has become a standard delivery channel in the U.S., particularly among younger generations, with nearly 30% of Generation Z and millennials using telehealth for their most recent healthcare encounter [8]

Core Viewpoint - Mobile-health Network Solutions has launched a $300 million At-the-Market equity offering to enhance its AI-powered healthcare and pharmacy delivery services, aiming to expand its reach in emerging markets [1][2]. Group 1: Offering Details - The company plans to use the net proceeds from the offering for critical initiatives that reinforce its leadership in digital healthcare, including the development of advanced large language models for medical diagnostics, expansion of AI-driven teleconsultation services, and building pharmacy delivery infrastructure [2][4]. - The offering is seen as a pivotal step towards creating a scalable, technology-enabled healthcare ecosystem, particularly in underserved regions [2][4]. Group 2: Company Overview - Mobile-health Network Solutions is a leading AI-powered digital health platform based in Singapore, with operations across Southeast Asia and plans to expand into the US [3]. - The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure, with a mission to make healthcare accessible and intelligent through technology [3].

Core Viewpoint - Mobile-health Network Solutions (MNDR) is transitioning to a leaner, asset-light model focused on AI-driven virtual care, aiming for scalability and profitability despite short-term revenue declines due to the closure of its CityGate clinic in Singapore [2][3]. Financial Performance - For H1 FY2025, MNDR reported revenue of US$4.3 million, down from US$6.6 million in H1 FY2024, and a net loss of US$(1.7 million) compared to US$(1.5 million) in the same period last year [7]. - Cash and cash equivalents decreased to US$2.6 million from US$6.7 million in H1 FY2024 [7]. Strategic Initiatives - The closure of the CityGate clinic is seen as a pivotal moment in the company's transformation towards a globally scalable, AI-focused platform [3]. - In April 2025, MNDR acquired Lifepack, enhancing its telehealth and pharmacy services for Indonesia's 280 million people, many of whom are underserved [4]. - The company secured US$10 million in funding in January 2025 to advance its AI-driven healthcare solutions, including the AI Agent platform [5]. Operational Developments - MNDR has integrated AI agents into its MaNaDr app to reduce operational costs while improving care and service delivery [8]. - The launch of AI Notes in March 2025 automates clinical note-taking for doctors, enhancing efficiency [11]. - A tele-dentistry service was announced in May 2025, allowing patients to perform AI-enhanced dental scans at home [11]. Future Outlook - The company anticipates that recent initiatives will lead to higher revenue and aims to achieve breakeven by H2 FY2025 and profitability before H1 FY2027 [9].

Company Overview - Mobile-health Network Solutions is a leading MedTech innovator ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies [4] - The company is the first telehealth provider from the Asia-Pacific region to be listed in the US, offering personalized and reliable medical attention globally [4] - Its platform enables healthcare providers to reach users through virtual clinics without start-up costs, connecting them to a global network of peer-to-peer support groups and partners [4] Share Repurchase Program - The Board of Directors has approved a share repurchase program to buy back up to 214,000 Class A Ordinary Shares, effective immediately for one year [1] - The program reflects the Board's confidence in the company's long-term growth prospects and is seen as a compelling use of capital at current share prices [2] - Repurchases may occur through various means, including open market transactions and privately negotiated transactions, depending on market conditions and regulatory requirements [2][3] Market Position and Strategy - The company believes its current share price does not reflect its intrinsic value or the strength of its fundamentals [2] - The share repurchase program does not obligate the company to repurchase a specific number of shares and can be modified or terminated at the company's discretion [3]

Core Insights - Mobile-health Network Solutions (MNDR) has launched a new tele-dentistry service that allows patients to perform AI-enhanced dental scans at home using the MNDR telemedicine app, with expert-reviewed reports delivered within 24 hours [2][3][4] - The service aims to encourage Southeast Asian patients, who often do not visit dentists regularly, to seek dental care more frequently [3][7] - The tele-dentistry package includes guided steps for capturing intraoral images and receiving AI-generated reports, which will highlight potential dental issues [4][5] Company Developments - MNDR has signed a Memorandum of Understanding (MOU) with Oral Link Pte Ltd and Elite Dental Group Singapore Pte Ltd to facilitate the tele-dentistry service [4][6] - The service is set to launch in Singapore in the summer of 2025, with plans for expansion into Malaysia, Indonesia, and the Philippines by mid-2026 [6] - MNDR will earn an appointment booking fee and platform usage fee for each tele-dentistry session [6] Industry Context - According to the World Health Organization, oral diseases affect nearly 3.7 billion people globally, with untreated dental caries being the most common health condition [9] - The introduction of AI-enabled dental scans is expected to improve early detection of dental issues, potentially increasing patient engagement in dental care [7][9]

Summary of the Conference Call for Mobile Health Network Solution (MNDR) Company Overview - **Company Name**: Mobile Health Network Solution - **Ticker**: MNDR - **Market**: Primarily focused on the APAC region, particularly Singapore, with plans for expansion into Indonesia, Malaysia, and Vietnam [1][26][57] Core Industry Insights - **Telehealth Market**: The company is a leading provider of teleconsultation services in Southeast Asia, with a significant volume of consultations conducted over the past seven years [5][33] - **AI Integration**: The company is leveraging AI technology to enhance healthcare delivery, including the development of an AI companion for patients and an AI adviser for doctors [28][31] Key Points and Arguments - **Market Position**: Ranked as one of the fastest-growing healthcare and life science companies in Singapore and the APAC region, with a Financial Times ranking of 41 in 2024 [5][26] - **User Base**: Over 2 million users in Singapore, with a high user retention rate of nearly 99% [42][56] - **Affordability**: Offers teleconsultation services at a cost of less than $6 to $7, making healthcare accessible and affordable [40] - **Growth Potential**: Less than 20% of care in Singapore is currently virtual, indicating significant growth potential as the company aims to scale virtual care [48][49] Future Plans and Strategies - **Expansion**: Plans to expand operations into Indonesia, Malaysia, and Vietnam, targeting a combined population of nearly 500 million [57][58] - **AI Development**: Focus on developing AI capabilities to automate clinical documentation and enhance patient-doctor interactions [31][54] - **Global Reach**: The platform is designed for global scalability, allowing users worldwide to access services through a mobile app [58] Financial Insights - **Liquidity**: The company has a standby line of $10 million and aims for operational profitability within one to two years [53][54] - **Marketing Strategy**: Minimal marketing expenditure (less than $100,000) with growth driven primarily by word-of-mouth [55] Additional Noteworthy Information - **Healthcare Transformation**: The company is positioned to redefine healthcare delivery through AI, aiming for a seamless interaction between patients and healthcare providers [44][60] - **Unique Value Proposition**: The combination of high consultation volume, healthcare-focused data accumulation, and AI-driven solutions sets the company apart from generalist AI solutions [63][64] Conclusion - The company is at the forefront of a transformative period in healthcare, leveraging AI to enhance accessibility and efficiency in telehealth services, with ambitious plans for growth and expansion in the coming years [41][62]